The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will once again support the seventh meeting in this series on GPCR drug discovery, combining cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
This meeting will be of interest to medicinal chemists, pharmacologists, computational chemists, structural biologists and all those involved in drug discovery.
SCI members attending this meeting are able to claim CPD points
Arthur Christopoulos,Monash University, Australia
Miles Congreve, Heptares Therapeutics, UK
Michael Hanson, GPCR Consortium, USA
Xiayang Qiu, Pfizer, USA
Daniel Rosenbaum, University of Texas Southwestern Medical Center, USA
Adrian Hall, UCB, Belgium
Caroline Low, Consultant, UK
Jon Mason, Heptares Therapeutics, UK
Fabrizio Micheli, Aptuit, Italy
David Miller, Inflazome, Ireland
Sarah Skerratt, Vertex, UK